American Cannabis Company, Inc.
American Cannabis Company, Inc. (AMMJ) Revenue
Annual & quarterly revenue history · segment & region breakdown
AMMJ · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAmerican Cannabis Company, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 86.84% year-over-year from $0.00B in FY2023.
Revenue trend
2023 – 2004 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-12-31 | $0.00B | -$0.02B | -86.84% |
| 2022-12-31 | $0.02B | +$0.02B | +675.63% |
| 2021-12-31 | $0.00B | +$0.00B | +54.46% |
| 2020-12-31 | $0.00B | -$0.00B | -26.33% |
| 2019-12-31 | $0.00B | +$0.00B | +116.93% |
| 2018-12-31 | $0.00B | -$0.00B | -59.79% |
| 2017-12-31 | $0.00B | +$0.00B | +56.50% |
| 2016-12-31 | $0.00B | -$0.00B | -44.25% |
| 2015-12-31 | $0.00B | +$0.00B | +122.40% |
| 2014-12-31 | $0.00B | -$0.01B | -83.79% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income American Cannabis Company, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
American Cannabis Company, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from American Cannabis Company, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AMMJ revenue · 4 questionsAMMJ's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 86.84% year-over-year from $0.00B in FY2023.
▸ Source: FMP · American Cannabis Company, Inc. SEC filings · GAAP · American Cannabis Company, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026